938 related articles for article (PubMed ID: 16275870)
21. Incidence of cardiovascular events and vascular interventions in patients with type 2 diabetes.
Engelen SE; van der Graaf Y; Stam-Slob MC; Grobbee DE; Cramer MJ; Kappelle LJ; de Borst GJ; Visseren FLJ; Westerink J;
Int J Cardiol; 2017 Dec; 248():301-307. PubMed ID: 28802735
[TBL] [Abstract][Full Text] [Related]
22. Metabolic syndrome as a predictor of cardiovascular diseases and type 2 diabetes in Koreans.
Hwang YC; Jee JH; Oh EY; Choi YH; Lee MS; Kim KW; Lee MK
Int J Cardiol; 2009 May; 134(3):313-21. PubMed ID: 19131127
[TBL] [Abstract][Full Text] [Related]
23. Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location.
Avogaro A; Giorda C; Maggini M; Mannucci E; Raschetti R; Lombardo F; Spila-Alegiani S; Turco S; Velussi M; Ferrannini E;
Diabetes Care; 2007 May; 30(5):1241-7. PubMed ID: 17290034
[TBL] [Abstract][Full Text] [Related]
24. Triglyceride-to-high-density-lipoprotein-cholesterol ratio is an index of heart disease mortality and of incidence of type 2 diabetes mellitus in men.
Vega GL; Barlow CE; Grundy SM; Leonard D; DeFina LF
J Investig Med; 2014 Feb; 62(2):345-9. PubMed ID: 24402298
[TBL] [Abstract][Full Text] [Related]
25. Components of metabolic syndrome and their combinations as predictors of cardiovascular disease in Japanese patients with type 2 diabetes. Implications for improved definition. Analysis from Japan Diabetes Complications Study (JDCS).
Sone H; Tanaka S; Iimuro S; Oida K; Yamasaki Y; Oikawa S; Ishibashi S; Katayama S; Ito H; Ohashi Y; Akanuma Y; Yamada N
J Atheroscler Thromb; 2009 Aug; 16(4):380-7. PubMed ID: 19672033
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of microalbuminuria versus the metabolic syndrome as a predictor of cardiovascular disease in women and men>40 years of age (from the Rancho Bernardo Study).
Jassal SK; Langenberg C; von Mühlen D; Bergstrom J; Barrett-Connor E
Am J Cardiol; 2008 May; 101(9):1275-80. PubMed ID: 18435957
[TBL] [Abstract][Full Text] [Related]
27. Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: a longitudinal cohort study.
Ramezankhani A; Azizi F; Hadaegh F
Cardiovasc Diabetol; 2022 Nov; 21(1):227. PubMed ID: 36324143
[TBL] [Abstract][Full Text] [Related]
28. Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies.
Ye X; Kong W; Zafar MI; Chen LL
Cardiovasc Diabetol; 2019 Apr; 18(1):48. PubMed ID: 30987625
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein.
Malik S; Wong ND; Franklin S; Pio J; Fairchild C; Chen R
Diabetes Care; 2005 Mar; 28(3):690-3. PubMed ID: 15735209
[TBL] [Abstract][Full Text] [Related]
30. Metabolic syndrome and mortality in older adults: the Cardiovascular Health Study.
Mozaffarian D; Kamineni A; Prineas RJ; Siscovick DS
Arch Intern Med; 2008 May; 168(9):969-78. PubMed ID: 18474761
[TBL] [Abstract][Full Text] [Related]
31. [Cardiovascular disease in patients with type 1 and type 2 diabetes in Spain].
Ortega E; Amor AJ; Rojo-Martínez G; Castell C; Giménez M; Conget I
Med Clin (Barc); 2015 Sep; 145(6):233-8. PubMed ID: 25561182
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of Metabolic Syndrome by different definitions, and its association with type 2 diabetes, pre-diabetes, and cardiovascular disease risk in Brazil.
do Vale Moreira NC; Hussain A; Bhowmik B; Mdala I; Siddiquee T; Fernandes VO; Montenegro Júnior RM; Meyer HE
Diabetes Metab Syndr; 2020; 14(5):1217-1224. PubMed ID: 32682310
[TBL] [Abstract][Full Text] [Related]
33. Fasting glucose levels within the high normal range predict cardiovascular outcome.
Shaye K; Amir T; Shlomo S; Yechezkel S
Am Heart J; 2012 Jul; 164(1):111-6. PubMed ID: 22795290
[TBL] [Abstract][Full Text] [Related]
34. Metabolic syndrome, diabetes, and cardiovascular disease in an elderly Caucasian cohort: the Italian Longitudinal Study on Aging.
Maggi S; Noale M; Gallina P; Bianchi D; Marzari C; Limongi F; Crepaldi G;
J Gerontol A Biol Sci Med Sci; 2006 May; 61(5):505-10. PubMed ID: 16720749
[TBL] [Abstract][Full Text] [Related]
35. Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in asian diabetic patients? Analysis from the Japan Diabetes Complications Study.
Sone H; Mizuno S; Fujii H; Yoshimura Y; Yamasaki Y; Ishibashi S; Katayama S; Saito Y; Ito H; Ohashi Y; Akanuma Y; Yamada N;
Diabetes Care; 2005 Jun; 28(6):1463-71. PubMed ID: 15920069
[TBL] [Abstract][Full Text] [Related]
36. Impaired fasting glucose cutoff value of 5.6 mmol/l combined with other cardiovascular risk markers is a better predictor for incident Type 2 diabetes than the 6.1 mmol/l value: Tehran lipid and glucose study.
Harati H; Hadaegh F; Tohidi M; Azizi F
Diabetes Res Clin Pract; 2009 Jul; 85(1):90-5. PubMed ID: 19414206
[TBL] [Abstract][Full Text] [Related]
37. Red blood cell count in short-term prediction of cardiovascular disease incidence in the Gubbio population study.
Puddu PE; Lanti M; Menotti A; Mancini M; Zanchetti A; Cirillo M; Angeletti M;
Acta Cardiol; 2002 Jun; 57(3):177-85. PubMed ID: 12088175
[TBL] [Abstract][Full Text] [Related]
38. Platelet mean volume, distribution width, and count in type 2 diabetes, impaired fasting glucose, and metabolic syndrome: a meta-analysis.
Zaccardi F; Rocca B; Pitocco D; Tanese L; Rizzi A; Ghirlanda G
Diabetes Metab Res Rev; 2015 May; 31(4):402-10. PubMed ID: 25421610
[TBL] [Abstract][Full Text] [Related]
39. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women.
Juutilainen A; Lehto S; Rönnemaa T; Pyörälä K; Laakso M
Diabetes Care; 2007 Feb; 30(2):292-9. PubMed ID: 17259497
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of dalcetrapib in type 2 diabetes mellitus and/or metabolic syndrome patients, at high cardiovascular disease risk.
Stalenhoef AF; Davidson MH; Robinson JG; Burgess T; Duttlinger-Maddux R; Kallend D; Goldberg AC; Bays H
Diabetes Obes Metab; 2012 Jan; 14(1):30-9. PubMed ID: 21819519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
